Sleep, Diabetic Retinopathy and Melatonin
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age40-65
SponsorUniversity of Illinois at Chicago
About this trial
This study explores the use of melatonin in patients with diabetic retinopathy
Eligibility criteria
Qualifiers
Type 2 diabetes (clinically diagnosed, taking anti-diabetes medications or history of elevated A1C≥6.5%)
40-65 years of age
Diabetic retinopathy of at least moderate degree
Disqualifiers
use of melatonin
antidepressants or antipsychotics
illicit drug use
night shift work or travel beyond 2 time zones in the month before enrollment
Trial design
Treatments tested in this trial
- Melatonin
- Placebo
Treatment groups
42 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Illinois at Chicago
Lead sponsor
University of Chicago
Collaborator
Source ClinicalTrials.gov